X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
peripheral vascular disease (17) 17
index medicus (16) 16
humans (13) 13
triglycerides (11) 11
japan (9) 9
k-877 (9) 9
adult (8) 8
atherosclerosis (7) 7
female (7) 7
male (7) 7
middle aged (7) 7
risk factors (7) 7
cholesterol (6) 6
coronary-heart-disease (6) 6
dyslipidemia (6) 6
spparm-alpha (6) 6
aged (5) 5
cardiovascular-disease (5) 5
pemafibrate (5) 5
risk (5) 5
statins (5) 5
care and treatment (4) 4
double-blind method (4) 4
familial hypercholesterolemia (4) 4
hyperlipidemia (4) 4
selective pparα modulator (4) 4
therapy (4) 4
atherosclerosis - prevention & control (3) 3
benzoxazoles - therapeutic use (3) 3
butyrates - therapeutic use (3) 3
cardiac & cardiovascular systems (3) 3
cardiovascular disease (3) 3
cardiovascular diseases - diagnosis (3) 3
cardiovascular diseases - prevention & control (3) 3
clinical trials (3) 3
diabetes (3) 3
diagnosis criteria (3) 3
double-blind (3) 3
dyslipidaemia (3) 3
endocrinology & metabolism (3) 3
fenofibrate - therapeutic use (3) 3
glucose (3) 3
glucose metabolism (3) 3
heart-disease (3) 3
heterozygote (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3) 3
hypertriglyceridemia - drug therapy (3) 3
hypolipidemic agents - therapeutic use (3) 3
ldl cholesterol (3) 3
lipoproteins (3) 3
low-density-lipoprotein (3) 3
metaanalysis (3) 3
metabolism (3) 3
ppar alpha - agonists (3) 3
prevention (3) 3
research (3) 3
risk-factors (3) 3
safety (3) 3
treatment outcome (3) 3
triglyceride (3) 3
triglyceride-rich lipoproteins (3) 3
triglycerides - blood (3) 3
type-2 diabetes-mellitus (3) 3
achilles tendon thickness (2) 2
acute coronary syndrome (2) 2
analysis (2) 2
apolipoprotein-b (2) 2
apolipoproteins (2) 2
association (2) 2
atherogenic dyslipidemia (2) 2
atherosclerosis - diagnosis (2) 2
atherosclerotic cardiovascular-diseases (2) 2
biomarkers - blood (2) 2
cardiology and cardiovascular medicine (2) 2
cardiovascular (2) 2
cardiovascular agents (2) 2
cardiovascular diseases - etiology (2) 2
cells (2) 2
cholesterol - metabolism (2) 2
cholesterol, hdl - blood (2) 2
cholesterol, hdl - metabolism (2) 2
cholesterol, ldl - blood (2) 2
cholesterol, ldl - metabolism (2) 2
combination (2) 2
complications and side effects (2) 2
coronary artery disease (2) 2
coronary-artery-disease (2) 2
density-lipoprotein cholesterol (2) 2
diabetes mellitus (2) 2
diagnosis (2) 2
disease management (2) 2
dosage and administration (2) 2
drug therapy (2) 2
dyslipidemias (2) 2
dyslipidemias - drug therapy (2) 2
dyslipidemias - prevention & control (2) 2
fatty acids (2) 2
fibrate (2) 2
fibroblast growth factor (2) 2
guidelines (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Atherosclerosis, ISSN 0021-9150, 06/2016, Volume 249, p. 36
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link:... 
Clinical trials | Medical colleges | Product development | Triglycerides | Cells | Cardiovascular agents | Low density lipoproteins | Statins
Journal Article
Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue Suppl_3 Suppl 3, pp. A13374 - A13374
BackgroundResidual cardiovascular risk remains despite intensive statin treatment. K-877, a Selective PPAR-α Modulator (SPPARMα), has shown significant... 
Journal Article
Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue Suppl_3 Suppl 3, pp. A12384 - A12384
BackgroundResidual cardiovascular risk remains despite intensive treatment with statins. K-877, a Selective PPAR-α Modulator (SPPARMα), has shown significant... 
Journal Article
Atherosclerosis, ISSN 0021-9150, 2017, Volume 261, pp. 144 - 152
Journal Article
Journal Article
Journal of Atherosclerosis and Thrombosis, ISSN 1340-3478, 2018
Aim: To verify the superiority of pemafibrate over placebo and the non-inferiority of pemafibrate to the maximum dose of fenofibrate for determining the... 
Selective PPARα modulator | Fibrate | Residual risk | Triglycerides | Safety
Journal Article
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 2019, Volume 20, Issue 3, p. 706
Pemafibrate (K-877) is a novel selective peroxisome proliferator-activated receptor-α modulator (SPPARMα) with a favorable benefit-risk balance. Previous... 
K-877 | Selective PPARα modulator | Renal dysfunction | Safety | High-density lipoprotein cholesterol | Triglyceride | Pemafibrate | Index Medicus | triglyceride | selective PPARα modulator | safety | high-density lipoprotein cholesterol | pemafibrate | renal dysfunction
Journal Article
DIABETES CARE, ISSN 0149-5992, 03/2018, Volume 41, Issue 3, pp. 538 - 546
OBJECTIVE Type 2 diabetes is frequently complicated with atherogenic dyslipidemia. This study aimed to evaluate the efficacy and safety of pemafibrate (K-877)... 
K-877 | CHOLESTEROL | FENOFIBRATE | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | RISK | CORONARY-HEART-DISEASE | SPPARM-ALPHA | INSULIN SENSITIVITY | IMPROVES DYSLIPIDEMIA | AGONIST | Index Medicus
Journal Article
Atherosclerosis, ISSN 0021-9150, 06/2017, Volume 261, p. 144
Substantial residual cardiovascular risks remain despite intensive statin treatment. Residual risks with high triglyceride and low high-density lipoprotein... 
Clinical trials | Medical colleges | Triglycerides | Statins | Cells | Cardiovascular agents | Complications and side effects | Blood lipids
Journal Article
Atherosclerosis (Supplements) (Component), ISSN 1567-5688, 06/2018, Volume 32, pp. 154 - 155
Journal Article
Atherosclerosis (Supplements) (Component), ISSN 1567-5688, 06/2018, Volume 32, pp. 155 - 155
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.